FREE Case Review (866) 588-0600

Farxiga Lawsuits Centralized in New York

A panel of judges has agreed to establish a multidistrict litigation for all federal product liability lawsuits involving Farxiga and Xigduo XR in New York.

A panel of judges has agreed to establish a multidistrict litigation (MDL) for all federal product liability lawsuits involving the type 2 diabetes medications Farxiga and Xigduo XR in the U.S. District Court, Southern District of New York.

Free Confidential Lawsuit Evaluation: If you or a loved one was injured by the side effects of Farxiga or Xigduo XR, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

What’s the problem?

April 12, 2017 – According to a Transfer Order (PDF) issued Thursday, at least 18 lawsuits alleging kidney damage or diabetic ketoacidosis from Farxiga or Xigduo XR have been filed in federal courts across the U.S.

Plaintiffs filed a petition with the U.S. Judicial Panel on Multidistrict Litigation (JPML) in February, stating that centralization would increase judicial efficiency. JPML agreed that the actions share factual questions arising from allegations, thus implicating numerous common issues concerning the development, manufacture, testing, regulatory history, promotion, and labeling of Farxiga and Xigduo XR.

Multidistrict litigations are common in cases where a large number of lawsuits alleging similar damages are filed against the same defendant. Centralization is intended to reduce duplicative discovery, avoid conflicting rulings by different judges, and to serve the convenience of all parties involved in the litigation process.

Both Farxiga and Xigduo XR are used to control blood sugar levels in patients with type 2 diabetes. They belong to a class of medicines known as sodium-glucose co-transporter 2 inhibitors, or SGLT2 inhibitors, that work by increasing the removal of sugar from the kidneys.

Last year, a separate MDL was created for lawsuits alleging kidney damage or ketoacidosis from two other SGLT2 inhibitors, Invokana and Invokamet. More than 120 lawsuits are currently pending in that litigation.

Do I Have a Farxiga Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Farxiga lawsuits. We are handling individual litigation nationwide and currently accepting new kidney problem and ketoacidosis cases in all 50 states.

Free Case Evaluation: Again, if you were harmed by the side effects of a diabetes medication, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*

Awards & recognition